On August 27, 2021, the Board of Directors of Landos Biopharma, Inc. appointed Fred Callori to serve as a director of the Company. Mr. Callori will serve as a Class II director whose term will expire at the 2023 Annual Meeting, at which time he will stand for election by the Company’s stockholders. Mr. Callori was also appointed to serve on the Audit Committee. On August 27, 2021, Konstantin Poukalov resigned from the board of directors. Mr. Poukalov’s decision to resign was not the result of any disagreement with the Company relating to its operations, policies or practices.